These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2516682)

  • 21. Epithelial differentiation in meningiomas. An immunohistochemical, histochemical, and ultrastructural study--with review of the literature.
    Radley MG; di Sant'Agnese PA; Eskin TA; Wilbur DC
    Am J Clin Pathol; 1989 Sep; 92(3):266-72. PubMed ID: 2476026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers.
    Rajaram V; Brat DJ; Perry A
    Hum Pathol; 2004 Nov; 35(11):1413-8. PubMed ID: 15668900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Meningiomas: immunohistochemical analysis of 26 cases].
    Pérez-Guiones Bacete M; Cerda-Nicolás M; Piquer J; Barcia-Mariño C
    Arch Neurobiol (Madr); 1992; 55(2):43-9. PubMed ID: 1377465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the proliferating cell nuclear antigen and clinicopathological features in intracranial meningiomas.
    Kim CH; Cheong JH; Bak KH; Kim JM; Oh SJ
    J Clin Neurosci; 2001 May; 8 Suppl 1():44-8. PubMed ID: 11386825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67.
    Roggendorf W; Schuster T; Peiffer J
    Acta Neuropathol; 1987; 73(4):361-4. PubMed ID: 3618128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
    Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
    Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.
    Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S
    Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade.
    Mahzouni P; Movahedipour M
    Pathol Res Pract; 2012 Apr; 208(4):221-4. PubMed ID: 22420924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunohistochemical study of mononuclear cells in meningiomas.
    Bø L; Mørk SJ; Nyland H
    Neuropathol Appl Neurobiol; 1992 Dec; 18(6):548-58. PubMed ID: 1488087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meningioma with eosinophilic granular inclusions.
    Alexander RT; McLendon RE; Cummings TJ
    Clin Neuropathol; 2004; 23(6):292-7. PubMed ID: 15584214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of neural cell-adhesion molecule isoforms and epithelial cadherin adhesion molecules in 47 human meningiomas: correlation with clinical and morphological data.
    Figarella-Branger D; Pellissier JF; Bouillot P; Bianco N; Mayan M; Grisoli F; Rougon G
    Mod Pathol; 1994 Sep; 7(7):752-61. PubMed ID: 7824509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of p63 immunoreactivity with tumor grade in meningiomas.
    Rushing EJ; Olsen C; Man YG
    Int J Surg Pathol; 2008 Jan; 16(1):38-42. PubMed ID: 18203782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD44 expression in human meningiomas: an immunohistochemical analysis.
    Lewy-Trenda I; Omulecka A; Janczukowicz J; Papierz W
    Pol J Pathol; 2004; 55(1):33-7. PubMed ID: 15195704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary ear and temporal bone meningiomas: a clinicopathologic study of 36 cases with a review of the literature.
    Thompson LD; Bouffard JP; Sandberg GD; Mena H
    Mod Pathol; 2003 Mar; 16(3):236-45. PubMed ID: 12640104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry.
    Nakaguchi H; Fujimaki T; Matsuno A; Matsuura R; Asai A; Suzuki I; Sasaki T; Kirino T
    Cancer; 1999 May; 85(10):2249-54. PubMed ID: 10326705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proliferative markers of meningiomas: immunohistochemical analysis and prognostic value].
    Korshunov AG; Shishkina LV; Golanov AV
    Arkh Patol; 2002; 64(1):29-33. PubMed ID: 11889696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of clinical and pathological features of secretory meningiomas].
    Li XJ; Zhang HY; Lang ZQ; Wei B; Chen HJ; Bu H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):488-91. PubMed ID: 16761441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibody analysis of major histocompatibility complex expression in human meningiomas.
    Becker I; Roggendorf W
    J Neuroimmunol; 1989 Dec; 25(2-3):161-7. PubMed ID: 2584394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of p63 protein expression with histological grade of meningiomas: an immunohistochemical study.
    Mittal S; Jain D; Roy S; Mehta VS
    Int J Surg Pathol; 2012 Aug; 20(4):349-54. PubMed ID: 22287651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.